
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/04/2025 | Q3 | $618.4M | -- | -- | $0.65 | -- |
06/04/2025 | Q2 | $603.5M | $629.1M | $0.38 | $0.57 | -$0.19 |
03/05/2025 | Q1 | $492.8M | $525.1M | $0.35 | $0.27 | $0.09 |
12/11/2024 | Q4 | $603.3M | $597.9M | $0.80 | $0.49 | $0.31 |
09/04/2024 | Q3 | $618.7M | $579.4M | $0.35 | $0.42 | -$0.07 |
06/05/2024 | Q2 | $601.4M | $616.9M | $0.28 | $0.26 | $0.02 |
03/06/2024 | Q1 | $580.8M | $586M | $3.06 | $0.15 | $2.92 |
12/13/2023 | Q4 | -- | -- | $0.50 | $0.34 | $0.16 |
09/13/2023 | Q3 | -- | -- | $0.25 | $0.23 | $0.02 |
06/08/2023 | Q2 | -- | -- | $0.24 | $0.18 | $0.06 |
03/08/2023 | Q1 | -- | -- | -$0.23 | -$0.01 | -$0.22 |
12/14/2022 | Q4 | -- | -- | $0.15 | $0.26 | -$0.11 |
09/07/2022 | Q3 | -- | -- | $0.16 | $0.22 | -$0.06 |
06/07/2022 | Q2 | -- | -- | -$0.04 | $0.24 | -$0.28 |
03/09/2022 | Q1 | -- | -- | -$0.01 | $0.11 | -$0.12 |
12/15/2021 | Q4 | -- | -- | -- | $0.29 | -- |
09/08/2021 | Q3 | -- | -- | $0.36 | $0.34 | $0.03 |
06/07/2021 | Q2 | -- | -- | $0.31 | $0.20 | $0.11 |
03/10/2021 | Q1 | -- | -- | -- | $0.06 | -- |
01/07/2021 | Q4 | -- | -- | -$0.16 | $0.19 | -$0.35 |
09/09/2020 | Q3 | -- | -- | -$0.06 | $0.01 | -$0.07 |
06/08/2020 | Q2 | -- | -- | -$0.12 | -$0.26 | $0.14 |
03/04/2020 | Q1 | -- | -- | -$0.15 | -$0.02 | -$0.13 |
12/18/2019 | Q4 | -- | -- | -$0.14 | $0.13 | -$0.27 |
09/04/2019 | Q3 | -- | -- | $0.21 | $0.43 | -$0.22 |
06/05/2019 | Q2 | -- | -- | $0.24 | $0.25 | -$0.01 |
03/06/2019 | Q1 | -- | -- | -$0.05 | $0.04 | -$0.09 |
12/19/2018 | Q4 | -- | -- | $0.28 | $0.53 | -$0.25 |
09/05/2018 | Q3 | -- | -- | $0.38 | $0.45 | -$0.07 |
06/06/2018 | Q2 | -- | -- | $0.24 | $0.35 | -$0.11 |
03/07/2018 | Q1 | -- | -- | $0.15 | $0.09 | $0.06 |
12/19/2017 | Q4 | -- | -- | $0.44 | $0.46 | -$0.02 |
09/07/2017 | Q3 | -- | -- | $0.33 | $0.31 | $0.02 |
06/07/2017 | Q2 | -- | -- | $0.29 | $0.25 | $0.04 |
01/31/2017 | Q1 | -- | -- | $0.11 | $0.10 | $0.01 |
REV Group reported $629.1M worth of top line sales in its most recent quarter.
REV Group announced earnings per share of $0.38 which represents a miss of analyst forecast a $0.57 per share.
REV Group reported $95.7M that represents $1.89 per share over the last quarter.
REV Group's earnings are forecast to decrease from $4.72 per share to $1.58 per share next year representing a decrease of -48.73%.
REV Group's next earnings date is September 4, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.